# Ertapenem

NDC: 51810-504
Generic name: ertapenem sodium
Labeler / Manufacturer: Qilu Antibiotics Pharmaceutical Co., Ltd.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20241031

FDA application: ANDA218067

## Active ingredients

- ERTAPENEM SODIUM: 1 g/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51810-504"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51810-504
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=44496f7c-8407-4765-9cd6-1daa619a6db6